- Home
- FEBO vs BFRG Comparison
FEBO vs BFRG Comparison
Compare FEBO & BFRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FEBO | BFRG |
|---|---|---|
| Founded | 1993 | 2017 |
| Country | Hong Kong | United States |
| Employees | N/A | N/A |
| Industry | | Retail: Computer Software & Peripheral Equipment |
| Sector | | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.4M | 8.6M |
| IPO Year | 2022 | 2022 |
Fundamental Metrics
Financial Performance| Metric | FEBO | BFRG |
|---|---|---|
| Price | $0.68 | $0.52 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 4.8K | ★ 251.6K |
| Earning Date | 05-15-2026 | 11-17-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 25.88 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $116,670.00 |
| Revenue This Year | N/A | $568.55 |
| Revenue Next Year | N/A | $573.08 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 79.49 |
| 52 Week Low | $0.61 | $0.43 |
| 52 Week High | $1.46 | $1.96 |
Technical Indicators
Market Signals| Indicator | FEBO | BFRG |
|---|---|---|
| Relative Strength Index (RSI) | 52.95 | 47.16 |
| Support Level | $0.65 | $0.44 |
| Resistance Level | $0.80 | $0.69 |
| Average True Range (ATR) | 0.08 | 0.03 |
| MACD | 0.01 | 0.00 |
| Stochastic Oscillator | 70.51 | 62.74 |
Price Performance
Historical ComparisonAbout FEBO Fenbo Holdings Limited
Fenbo Holdings Ltd is a company engaged in producing premium personal care electric appliances, principally electrical hair styling products such as straighteners, curlers, trimmers, etc., and toy products to overseas markets. It manufactures and sells products such as Straightener, Mini Straightener, and Curling Iron.
About BFRG Bullfrog AI Holdings Inc.
Bullfrog AI Holdings Inc is a clinical-phase Biotechnology company using machine learning to advance medicine and improve human health. It uses artificial intelligence and machine learning to advance medicines for both internal and external projects. The Company is focused specifically on advance artificial intelligence and machine learning (AI/ML)- driven analysis of complex datasets in medicine and healthcare. The Company's objective is to use its AI/ML platform to provide a precision-medicine approach to drug-asset enablement through external partnerships and selective internal development.